Showing 6941-6950 of 8649 results for "".
- Oxurion Enrolls First Patient in Phase 1 Clinical Trial Evaluating THR-687 for Treatment of DMEhttps://modernod.com/news/oxurion-enrolls-first-patient-in-phase-1-clinical-trial-evaluating-thr-687-for-treatment-of-dme/2479860/Oxurion announced the enrollment of the first patient in a phase 1 open-label, multicenter, dose escalation study evaluating the safety of a single intravitreal injection of THR-687 for the treatment of patients with diabetic macula edema (DME). THR-687 is a novel pan-RGD integrin antagoni
- Oxurion Enrolls First Patient in Phase 2 Study Evaluating THR-317 for Treatment of Idiopathic Macular Telangiectasia Type 1https://modernod.com/news/oxurion-enrolls-first-patient-in-phase-2-study-evaluating-thr-317-for-treatment-of-idiopathic-macular-telangiectasia-type-1/2479863/Oxurion, formerly ThromboGenics, announced that it has enrolled the first patient in a phase 2 open-label multicenter study evaluating the efficacy and safety of intravitreal THR-317, an anti-PIGF (human placental growth factor) antibody, for the treatment of Macular Telangiectasia Type 1 (MacTel
- Topcon Announces Appointment of Gregory Hoffmeyer to Director of OCT Clinical Saleshttps://modernod.com/news/topcon-announces-appointment-of-gregory-hoffmeyer-to-director-of-oct-clinical-sales/2479902/Gregory Hoffmeyer has joined the Topcon sales team as director of OCT clinical sales. Mr. Hoffmeyer will be reporting to Corey Nielson, vice president of sales. Mr. Hoffmeyer previously worked as the senior cli
- Orbis and Visulytix Unveil Collaboration to Integrate AI Into Global Eye Health Effortshttps://modernod.com/news/orbis-and-visulytix-unveil-collaboration-to-integrate-ai-into-global-eye-health-efforts/2479903/Eye doctors in low-resource countries will receive sophisticated diagnostic technology thanks to a new collaboration between Orbis International, a nonprofit organization fighting global blindnes
- FDA Finalizes Guidance on Integrating EHRs Into Clinical Trialshttps://modernod.com/news/fda-finalizes-guidance-on-integrating-ehrs-into-clinical-trials/2479961/The FDA recently finalized an eagerly awaited guidance on the incorporation of electronic health records and real-world data into clinical trials and product submissions, including the use of patient medical histories, pharmacy records, radiology scans and lab test results from routine care, incl
- Bausch + Lomb Retina News, Eventshttps://modernod.com/news/bausch-lomb-retina-news-events/2480011/In advance of this week’s ASRS meeting, Bausch + Lomb Vice President and general manager of Surgical, Chuck Hess, distributed a customer letter to surgeons providing them an update on our progress in retina. The letter is below: Dear Eye Care Professional: At this time last y
- Iridex Reaches Milestone of 1000th Cyclo G6 System Shippedhttps://modernod.com/news/iridex-reaches-milestone-of-1000th-cyclo-g6-system-shipped/2480033/Iridex announced that in the second quarter of 2018 it shipped the 1,000th unit of its »Cyclo G6 Laser System, which utilizes the company’s propri
- Retinal Thinning Tied to Cognitive Declinehttps://modernod.com/news/retinal-thinning-tied-to-cognitive-decline/2480058/Thinning of the eye’s retinal nerve fiber layer (RNFL) appears to be a strong predictor of cognitive decline, new research shows, according to a report in Medscape. Investigators found healthy individuals with RNFL thinning w
- OD-OS Introduces the Navilas expertLibrary Forum for Retina Specialistshttps://modernod.com/news/od-os-introduces-the-navilas-expertlibrary-forum-for-retina-specialists/2480093/OD-OS has introduced a new forum for retina specialists – the Navilas expertLibrary. The Navilas expertLibrary is an exclusive forum where leading retinal physicians share their day-to-day experience with this novel navigated retinal laser technology, according to OD-OS. Interested parties
- Quantel Medical Creates a New Subsidiary in Polandhttps://modernod.com/news/quantel-medical-creates-a-new-subsidiary-in-poland/2480102/Quantel Medical has announced the opening of its new Polish subsidiary: Quantel Medical Polska. The new location will commercialize the complete range of ultrasound, laser, and dry eye diagnostics products. Quantel Me